Literature DB >> 12574547

Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study.

Søren P Johnsen1, Lars Pedersen, Søren Friis, William J Blot, Joseph K McLaughlin, Jørgen H Olsen, Henrik T Sørensen.   

Abstract

BACKGROUND AND
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) have effects on hemostasis and have been associated with an increased risk of bleeding. However, data relating the use of nonaspirin NSAIDs and risk of intracerebral hemorrhage (ICH) are sparse.
METHODS: Using data from the County Hospital Patient Register and the Civil Registration System of North Jutland County, Denmark, we identified 912 cases of first-time ICH and 9059 sex- and age-matched population-based controls in the period of 1991 to 1999. All prescriptions for nonaspirin NSAIDs before the date of admission for ICH were identified through a population-based prescription database. Conditional logistic regression was used to adjust for potential confounding factors, including previous discharge diagnoses of hypertension, chronic bronchitis and emphysema, alcoholism, liver cirrhosis, diabetes mellitus, and prescriptions for insulin or oral hypoglycemic agents, antihypertensive agents, lipid-lowering agents, low-dose aspirin, high-dose aspirin, and oral anticoagulants.
RESULTS: No overall association was found between prescription for nonaspirin NSAIDs in the preceding 30, 60, or 90 days and risk of ICH; ie, odds ratios ranged from 0.92 (95% CI, 0.70 to 1.21) to 1.13 (95% CI, 0.81 to 1.58). Furthermore, there was no increased risk of ICH associated with prescription for nonaspirin NSAIDs when the study population was stratified by age, sex, and a previous discharge diagnosis of hypertension.
CONCLUSIONS: Patients prescribed nonaspirin NSAIDs were not at an overall increased risk of being hospitalized for ICH. This reassuring finding was seen in all examined subgroups, including the elderly and patients with a previous discharge diagnosis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574547     DOI: 10.1161/01.str.0000054057.11892.5b

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

Review 1.  Update on intracerebral haemorrhage.

Authors:  José M Ferro
Journal:  J Neurol       Date:  2006-05-06       Impact factor: 4.849

2.  Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.

Authors:  Jaume Roquer; Ana Rodríguez Campello; Meritxell Gomis; Angel Ois; Victor Puente; Elvira Munteis
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

3.  Effects of intracerebral hemorrhage and subsequent minimally invasive hematoma aspiration on expression of apoptosisrelated genes in rats.

Authors:  Qinghua Zhang; Qianqian Tang; Xianghua Li; Jincun Li; Liping Zhang; Chuanzhu Yan; Yuanxiao Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

5.  Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study.

Authors:  Lotte G Welinder; Anders H Riis; Lars L Knudsen; Reimar W Thomsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

6.  Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.

Authors:  Andrew M Naidech; Sarice L Bassin; Richard A Bernstein; H Hunt Batjer; Mark J Alberts; Paul F Lindholm; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

7.  Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study.

Authors:  Ju-Young Shin; Mi-Ju Park; Shin Haeng Lee; So-Hyun Choi; Mi-Hee Kim; Nam-Kyong Choi; Joongyub Lee; Byung-Joo Park
Journal:  BMJ       Date:  2015-07-14

8.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.

Authors:  Carola A Huber; Thomas D Szucs; Roland Rapold; Oliver Reich
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

9.  Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions.

Authors:  Sigrun Alba Johannesdottir; Erzsébet Horváth-Puhó; Vera Ehrenstein; Morten Schmidt; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2012-11-12       Impact factor: 4.790

10.  Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study.

Authors:  Henning Grønbaek; Søren P Johnsen; Peter Jepsen; Mette Gislum; Hendrik Vilstrup; Ulrik Tage-Jensen; Henrik T Sørensen
Journal:  BMC Gastroenterol       Date:  2008-05-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.